Evaluation of P53, P63, P21, P27, Ki-67 in Paranasal Sinus Squamous Cell Carcinoma and Inverted Papilloma

Indian Journal of Otolaryngology and Head and Neck Surgery

Volumn 63, Issue 2, 2011, Pages 172-177

  Oncel, Semih ^a   Cosgul, Tulin ^a   Calli, Aylin ^b   Calli, Caglar ^a   Pinar, Ercan ^a  

^a Izmir Ataturk Training and Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Cell cycle regulators; Inverted papilloma; MIB 1; p21; p53; p63; Sinonasal squamous cell carcinoma

Indexed keywords

EID: 79960063917     PISSN: 22313796     EISSN: 09737707     Source Type: Journal    
DOI: 10.1007/s12070-011-0252-4     Document Type: Article

References (36)

1. Lampertico P, Russel WO, Maccomb WS (1963) Squamous papilloma of upper respiratory epithelium. Arch Pathol. 75: 293-302.
2. Batsakis JG (1979) Tumours of the head and neck, 2nd edn. Williams & Wilkins, Baltimore.
3. Hyams VJ (1971) Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 80: 192-206.
4. Buchwald C, Franzmann M-B, Tos M (1995) Sinonasal papillomas: a report of 82 cases in Copenhagen County, including a longitudinal epidemiological and clinical study. Laryngoscope 105: 72-79.
5. Lawson W, Kaufman MR, Biller HF (2003) Treatment outcomes in the management of inverted papillomas: an analysis of 160 cases. Laryngoscope 113: 1548-1556.
6. Barnes L (2002) Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol 15(3): 279-297. Review.
7. von Buchwald C, Bradley PJ (2007) Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 15(2): 95-98. Review.
8. Sherr CJ (1999) Roberts JM CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
9. Harper JW, Adami GR, Wie N et al (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
10. Xiong Y, Hannon GJ, Zang H, Casso D, Kobayashi R (1993) Beach D p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
11. Michieli P, Chedid M, Lin D et al (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395.
12. Steeg PS, Abrams JS (1997) Cancer prognostics: past, present and p27. Nat Med 3: 152-154.
13. Sgambato A, Cittadini A, Faraglia B, Weinstein IB (2000) Multiple functions of p27 (Kip1) and its alterations in tumor cells: a review. J Cell Physiol 183: 18-27.
14. Gerdes J, Lemke H, Baisch H et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715.
15. Phillips PP, Gustafson RO, Facer GW (1996) The clinical behavior of inverting papilloma of the nose and paranasal sinuses: Report of 112 cases and review of the literature. Laryngoscope 100: 463-469.
16. Katori H, Nozawa A, Tsukuda M (2005) Markers of malignant transformation of sinonasal inverted papilloma. [Comparative Study. Journal Article] Eur J Surg Oncol 31(8): 905-911.
17. Califano J, Koch W, Sidransky D, Westra WH (2000) Inverted sinonasal papilloma: a molecular genetic appraisal of its putative status as a precursor to squamous cell carcinoma. Am J Pathol 156(1): 333-337.
18. Keles N, Erdamar B, Kaur A, Deger K (2003) p21, p53, and p27 Kip1 alterations in benign and malignant tumors of sinonasal epithelium. Otolaryngol Head Neck Surg 129(1): 77-84.
19. Garavello W, Vigano P, Romagnoli M, Sordo L, Berti E, Tredici G, Gaini RM (2005) Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps. Am J Rhinol 19(6): 549-553.
20. Yang A, Kaghad M, Caput D et al (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90-95.
21. Ramalho FS, Ramalho LN, Della Porta L et al (2006) Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma. J Gastroenterol Hepatol 21(8): 1276-1278.
22. Fang SY, Yan JJ, Ohyama M (1998) Assessment of p53 protein expression in normal mucosa and benign and malignant lesions of the nasal cavity. Oncology 55: 168-173.
23. Mirza N, Montone K, Sato Y, Kroger H, Kennedy DW (1998) Identification of p53 and human papillomavirus in schneiderian papillomas. Laryngoscope 108: 497-501.
24. Di Como CJ, Urist MJ, Babayan I et al (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8(2): 494-501.
25. Tonon G, Wong KK, Maulik G et al (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102(27): 9625-9630. Epub 2005 June 27.
26. Guo C, Pan ZG, Li DJ (2006) The expression of p 63 is associated with the differential stage in nasophayngeal carcinoma and EBV infection. J Transl Med 4: 23.
27. Sniezek JC, Matheny KE, Burkey BB et al (2002) Expression of p63 and 14-3-3 in normal and hyperdifferentiated mucosa of the upper aerodigestive tract. Otolaryngol. Head Neck Surg 126: 598-601.
28. Pelosi G, Pasini F, Olsen Stenholm C et al (2002) p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 198: 100-109.
29. Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA (2004) Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 114(12): 2063-2072.
30. Massion PP, Taflan PM, Jamshedur Rahman SM et al (2003) Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63(21): 7113-7121.
31. Gujrathi C, Pathak I, Freeman J, Asa S (2003) Expression of p53 in inverted papilloma and malignancy associated with inverted papilloma. J Otolaryngol 32(1): 48-50.
32. Katori H, Nozawat A, Tsukuda M (2006) Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal-inverted papilloma. Clin Oncol (R Coll Radiol) 18(4): 300-305.
33. Ikegawa K, Matsukuma S (2005) Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions. Rinsho Byori 53(6): 499-503 (In article).
34. Michieli P, Chedid M, Lin D et al (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54(13): 3391-3395.
35. Saegusa M, Nitta H, Hashimura M, Okayasu I (1999) Down-regulation of p27Kip1 expression is correlated with increased cell proliferation but not expression of p21waf1 and p53, and human papillomavirus infection in benign and malignant tumours of sinonasal regions. Histopathology 35(1): 55-64.
36. Choi HR, Tucker SA, Huang Z et al (2003) Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 22(2): 409-414.